ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,091Medicare Part D Prescriptions Filled, Including Refills

Rank: 138 out of 1006

$551K Total Retail Price of All Prescriptions

Rank: 184 out of 1006

604 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 604 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 8,915 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
ATORVASTATIN CALCIUM 604 578 1 5
SIMVASTATIN 577 573 2 1
LEVOTHYROXINE SODIUM 493 493 3 2
AMLODIPINE BESYLATE 347 347 4 4
LISINOPRIL 318 317 5 3
LIPITOR 239 239 6 47
SYNTHROID 225 215 7 42
WARFARIN SODIUM 203 178 8 8
ZOLPIDEM TARTRATE 197 197 9 14
METOPROLOL SUCCINATE 191 191 10 12
AZITHROMYCIN 189 186 11 39
HYDROCHLOROTHIAZIDE 176 176 12 11
ALLOPURINOL 170 170 13 31
METFORMIN HCL 150 150 14 10
ESCITALOPRAM OXALATE 143 143 15 27
ATENOLOL 134 134 16 13
AMLODIPINE BESYLATE-BENAZEPRIL 133 133 17 77
DIGOXIN 129 129 18 52
PRAVASTATIN SODIUM 116 111 19 15
FUROSEMIDE 104 97 20 6
AZOR 99 99 21 198
BENICAR HCT 97 97 22 120
CRESTOR 95 90 23 18
DONEPEZIL HCL 94 94 24 17
SERTRALINE HCL 90 85 25 19
DIOVAN 87 87 26 16
BENICAR 80 69 27 78
DIOVAN HCT 80 80 27 60
OMEPRAZOLE 79 79 29 9
CARVEDILOL 79 75 29 36
AMOX TR-POTASSIUM CLAVULANATE 69 67 31 123
PANTOPRAZOLE SODIUM 66 58 32 32
ADVAIR DISKUS 64 61 33 37
CITALOPRAM HBR 62 62 34 24
NASONEX 61 61 35 176
CIPROFLOXACIN HCL 59 56 36 75
TRIAMTERENE-HCTZ 57 57 37 58
LOSARTAN POTASSIUM 57 48 37 22
METOPROLOL TARTRATE 56 56 39 7
AMITRIPTYLINE HCL 55 55 R 40 150
NEXIUM 55 54 40 28
CELEBREX 53 52 42 90
CLOPIDOGREL 53 49 42 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.